Delivery Order SPE2DB20D9226-SPE2DB25FD1BT
- Not listed
- On August 7, 2025, the Defense Logistics Agency awarded a firm fixed-price delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, identified as 4569023499, is for 60 tablets of Xtandi 80 mg, an oncology medication. This award was issued without a set-aside designation and carries an ultimate completion date of August 8, 2025. The order represents a single delivery under DMS...
- On August 22, 2025, the Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $23,366.04 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, numbered 4569186045, calls for the supply of 60 tablets of Xtandi 80 mg, an oncology medication used in the treatment of prostate cancer. This award represents a single delivery order issued under DMS Pharmaceutical Group's existing...
- On August 1, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $4,311.35 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, issued under contract number 4568977608, calls for the supply of Xtandi 40 mg capsules in quantities of 120 units, with an ultimate completion date of August 4, 2025. This award was made on a firm fixed-price basis with no set-aside designation, leveraging...
- The Defense Logistics Agency awarded a delivery order valued at $16,961.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 120 capsules of Xtandi 40 mg. This firm fixed-price delivery order, issued on September 16, 2025, with an ultimate completion date of September 17, 2025, represents a specialized pharmaceutical supply requirement supporting Department of Defense healthcare operations. The award carries no set-aside...
- On August 11, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $8,622.72 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order covers 120 capsules of Xtandi 40 mg, an oncology treatment medication, under a firm fixed-price contract with an ultimate completion date of August 12, 2025. This award was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete...
- On September 16, 2025, the Defense Logistics Agency awarded a delivery order valued at $8,339.18 to DMS Pharmaceutical Group Inc. for 60 tablets of Xtandi 80 mg, an oral medication used in oncology treatment. This firm fixed-price delivery order, issued without a set-aside designation, represents a single issuance under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026. The performance location is...
- The Defense Logistics Agency awarded a delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg tablets (120-count units). This firm fixed-price delivery order, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a discrete procurement action under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA. The award...
- On July 28, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, numbered 4568915549, covers the supply of Xtandi 40 mg tablets (120-count units), an oncology medication used in the treatment of prostate cancer. This firm fixed-price delivery order is scheduled for completion by July 29, 2025, with performance to take place...
- On September 11, 2025, the Defense Logistics Agency awarded a delivery order valued at $8,622.72 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, designated as Contract Number 4569422161, calls for the supply of Xtandi 40 mg capsules in a quantity of 120 units. This award represents a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and was issued without a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,868.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on September 4, 2025. This firm fixed-price delivery order covers the supply of Xtandi 40 mg capsules (120-count units), an oncology medication used in prostate cancer treatment. The contract carries no set-aside designation and is scheduled for ultimate completion by September 5, 2025, with...
- SPE2DB20D9226Indefinite Delivery Contract
- SPE2DB20D9226-SPE2DB25FD1BTDelivery Order
On September 16, 2025, the Defense Logistics Agency awarded a firm fixed-price delivery order valued at $16,678.36 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order (4569478146) is for 120 tablets of Xtandi 40 mg, an oncology medication, with an ultimate completion date of September 17, 2025. This award was issued without a set-aside designation, leveraging DMS Pharmaceutical Group's competitive capabilities as a woman-owned small business in the federal procurement marketplace. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, which carries a ceiling value of $499,999,999 and remains valid through November 2026. The IDC enables the DLA to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables, to support medical supply requirements across Department of Defense healthcare facilities worldwide. As a critical supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has demonstrated consistent success in delivering specialized pharmaceutical products to military health systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.7k | 9/16/25 |